(1) Á¦ 1ȸ ±¹Á¦ÀüÇØÁúÁúȯ ¿öÅ©¼¥ °³ÃÖ

- ⸳±â³äÀ¸·Î ±¹Á¦Çмú´ëȸ¿Í ±¹³»Çмú´ëȸÀÇ Joint Çмú´ëȸ Çü½ÄÀ¸·Î Ä¡·ïÁü
2002³â 5¿ù 11ÀÏ-12ÀÏ, ¿¬±¸È¸ ⸳À» ±â³äÇϴ ù¹øÂ° ±¹Á¦ÀüÇØÁúÁúȯÇмú´ëȸ¸¦ ÇѾç´ëÇб³ ¹é³²ÇмúÁ¤º¸°ü ±¹Á¦È¸Àǽǿ¡¼­ 351¿©¸íÀÌ Âü¼®ÇÑ °¡¿îµ¥ °³ÃÖÇÏ¿´´Ù.

¿Ü±¹ ¿¬»ç·Î´Â ij³ª´Ù Åä·ÐÅä´ëÇÐ Halperin ±³¼ö°¡ ´ë»ç¼º »êÁõ¿¡ ´ëÇÑ Æø³ÐÀº °³³äÀ» ½É¾î ÁÖ¾ú°í, ¹Ì±¹ ´º¿åÁÖ¸³´ëÇÐÀÇ Man Oh ±³¼öÀÇ ³ªÆ®·ý´ë»ç º´Å»ý¸®, ÀϺ» µ¿ÇØ(Tokai)Àǰú´ëÇÐÀÇ Kurokawa ±³¼öÀÇ Ä®½·´ë»ç¿¡ °üÇÑ °­¿¬ µîÀÌ ÀÖ¾ú´Ù. ±×¸®°í ¼Ò±×·ì Åä·ÐÀ» ½ÃµµÇÔÀ¸·Î½á ÀüÇØÁú´ë»çºÐ¾ß ¿öÅ©¼¥À» ÁøÇàÇÏ¿© »õ·Ó°íµµ ¼ÒÁßÇÑ °æÇèÀ» ¾ò°Ô µÇ¾ú´Ù. ±¹³» ¿¬»ç·Î´Â ÇÑ´ë¼® ±³¼ö(¿¬¼¼ÀÇ´ë), °­¼º±Í ±³¼ö(ÀüºÏÀÇ´ë), ±è±ÙÈ£ ±³¼ö(ÇѸ²ÀÇ´ë), ±èÈ£Áß ±³¼ö(ÇѾçÀÇ´ë)°¡ ³ªÆ®·ý ¹× Ä®·ýÀÌ»óÁõÀÇ Ä¡·áÀû Á¢±Ù¿¡ ´ëÇÏ¿© ¹ßÇ¥ÇÏ¿´´Ù.
Çмú´ëȸ¿¡¼­ ¹ßÇ¥µÈ ¿¬Á¦µéÁß ÀϺθ¦ »õ·Ó°Ô ÆíÁýÇÏ¿© ½ÅÀåÇÐ ±¹Á¦ÇмúÁö Nephron¿¡ supplement [92(suppl 1) 1-60, 2002]·Î ¹ß°£ÇÏ¿´´Ù.

(2) Á¦1ȸ Á¤±âÇмú´ëȸ¿Í ÇмúÁö â°£

2003³â 3¿ù 8ÀÏ, [´ëÇÑÀüÇØÁú´ë»ç¿¬±¸È¸] Á¦1ȸ Çмú´ëȸ°¡ °¡Å縯ÀǰúÇבּ¸¿ø¿¡¼­ ¼ºÈ²¸®¿¡ °³ÃֵǾú°í, "´ëÇÑÀüÇØÁú´ë»ç¿¬±¸È¸Áö" Ⱓȣ¸¦ ¹ßÇàÇÏ¿´´Ù. ÀÌ Çмú´ëȸ¿¡¼­´Â ½ÅÀå ³×ÇÁ·ÐÀÇ ÇØºÎÇÐÀû ±¸Á¶¿Í ±â´É(°¡Å縯ÀÇ´ë, ±èÁø) ±×¸®°í ¼¼´¢°ü¿¡¼­ ÀÌ¿ÂÅë·Î¿Í ¿î¹Ýü ´Ü¹é(ÇѸ²ÀÇ´ë, ±è±ÙÈ£), ¼öºÐ´ë»ç¿¡¼­ ¼¼´¢°ü AquaporinÀÇ ºÐÀÚ»ý¸®(µ¿±¹ÀÇ´ë, ±ÇÅÂȯ) ¹× ½ÅÀå¿¡¼­ ÀÌ´¢È£¸£¸óÀÇ º´Å»ý¸®(Àü³²ÀÇ´ë, ±è¼ö¿Ï) µîÀÇ ±âÃÊÀûÀÎ ¿¬±¸³í¹®ÀÌ ¹ßÇ¥µÇ¾úÀ¸¸ç, ÀÓ»ó ÀÀ¿ë¸é¿¡¼­ ½Å¼¼´¢°ü H+ó¸® °úÁ¤ÀÇ °Ë»ç(°¡Å縯ÀÇ´ë, ÀåÀ±½Ä)À» ¹ßÇ¥ÇÏ¿´´Ù.

¶ÇÇÑ Áõ·Êº¸°í¿¡¼­´Â ÇѾà(aristolochic acid)¿¡ ÀÇÇÑ ½Åº´Áõ(ÇѾçÀÇ´ë, ÇÑ»ó¿õ) ¹ß»ý¿¡ ´ëÇÑ °Í°ú ÀÌ´¢Á¦ ³²¿ëÀ¸·Î À¯¹ßµÉ ¼ö ÀÖ´Â Gitelman ÁõÈıº(¿ø±¤ÀÇ´ë, ¼ÛÁÖÈï)°ú ¿øÀκҸíÀÇ Gitelman ÁõÈıº(ÀüºÏÀÇ´ë, ±è¿ø) ±×¸®°í Sjogren ÁõÈıº½Ã ½Å¼¼´¢°ü »êÁõ µî ´Ù¾çÇÑ ÀüÇØÁú °ü·Ã Áõ·ÊµéÀÌ ¹ßÇ¥µÇ¾ú´Ù.

(3) Á¦2ȸ Á¤±âÇмú´ëȸ

2004³â 2¿ù 21ÀÏ, [´ëÇÑÀüÇØÁú´ë»ç¿¬±¸È¸] Á¦2ȸ Çмú´ëȸ°¡ °¡Å縯ÀǰúÇבּ¸¿ø¿¡¼­ ¼ºÈ²¸®¿¡ °³ÃֵǾú´Âµ¥, Molecular Pathogenesis of Nephrogenic Diabetes Insipidus(¼­¿ïÀÇ´ë Á¤ÇØÀÏ), Renal Hypophosphatemic Rickets (Osteomalacia)(¼­¿ïÀÇ´ë ÃÖ ¿ë), Bartter¡¯s & Gitelman¡¯s syndrome(Àü³²ÀÇ´ë ÃÖ±âö), Oxidative Stress and the Kidney(ÇѸ²ÀÇ´ë ±¸ÀÚ·æ), Heme Oxygenase in Kidney Disease(°æ»óÀÇ´ë À弼ȣ), Osmotic Stress and the Kidney(¼­¿ïÀÇ´ë ³ª±â¿µ), Natriuretic Peptides in the Kidney in Hypertension(Àü³²ÀÇ´ë ÀÌÁ¾Àº) µî ±¹³»¿¬Á¦°¡ ¹ßÇ¥µÇ¾ú°í Ưº°¿¬ÀÚ·Î Nippon Medical School, Yasuhiko Iino ±³¼öÀÇ Management of Hyperkalemia in ESRD°¡ ¹ßÇ¥µÇ¾ú´Ù.

(4) ´ëÇÑÀüÇØÁúÇÐȸ·Î ¸íĪº¯°æ

2004³â 6¿ù 4ÀÏ, ¼­¿ï Àá½Ç ·Ôµ¥¿ùµåÈ£ÅÚ¿¡¼­ º»È¸´Â ¿¬±¸È¸ ¿î¿µÀ§¿øÈ¸¸¦ °³ÃÖ(Âü¼®ÀÚ: ȸÀå, ºÎȸÀå, °¨»ç, Ãѹ«À§¿øÀå, ÇмúÀ§¿øÀå(±âÃÊ, ÀÓ»ó) ¹× °£»ç 7¸í)ÇÏ°í ´ëÇÑÀüÇØÁú´ë»ç¿¬±¸È¸¸¦ ´ëÇÑÀüÇØÁúÇÐȸ·Î ¸íĪÀ» º¯°æÇϱâ·Î °áÀÇÇÏ°í ÆòÀÇ¿øÈ¸ ¹× ÀÓ½ÃÃÑȸ¿¡¼­ °áÁ¤Å°·Î ÇÏ¿´´Ù. 2004³â 10¿ù 15ÀÏ, °æÁÖ Çö´ëÈ£ÅÚ¿¡¼­ ÆòÀÇ¿øÈ¸, ÀÓ½ÃÃÑȸ¸¦ °³ÃÖÇÏ°í ´ëÇÑÀüÇØÁúÇÐȸ·ÎÀÇ ¸íĪº¯°æÀ» °áÁ¤ÇÏ¿´´Ù. ÀÌ¿ÍÇÔ²² °ü·ÃµÈ ȸĢ µîÀ» °³Á¤ÇÏ¿´´Ù.

(5) Á¦3ȸ Á¤±âÇмú´ëȸ °³ÃÖ ¹× ¿µ¹®ÇмúÁö·Î Àüȯ

2005³â 3¿ù 5ÀÏ, [´ëÇÑÀüÇØÁúÇÐȸ] Á¦3Â÷ Á¤±âÇмú´ëȸ°¡ °¡Å縯ÀǰúÇבּ¸¿ø¿¡¼­ °³ÃֵǾú´Ù. Renal sodium handling and hypertension, Dietary salt and potassium intake and hypertension, Dysregulation of BP in diseased kidneys µî ÀüÇØÁú ¿¬Á¦¿Ü¿¡ Ç÷¾ÐÀÇ º´Å»ý¸®¿Í °üÇÑ ¿¬Á¦µéÀÌ ¹ßÇ¥µÇ¾ú´Ù.
¶ÇÇÑ ÀüÇØÁú ºÐ¾ß¿Í ÇÔ²² Ç÷¾ÐÀÇ º´Å»ý¸®¸¦ ´Ù·ç´Â ÇÐȸ·ÎÀÇ º¯È­¿¡ ¸ÂÃß¾î ±âÁ¸ ´ëÇÑÀüÇØÁú´ë»ç¿¬±¸È¸Áö´Â Àü¸éÀûÀÎ ¿µ¹®ÇмúÁö [Electrolyte & Blood Pressure]·Î °³ÆíµÇ¾ú´Ù.
ÇâÈÄ ±âÃÊ ¹× ÀÓ»óÀÇÇÐ °¢ ºÐ¾ßÀÇ ÇÐÀÚµéÀÌ º» ÇÐȸÀÇ ÃëÁö¿¡ Àû±Ø µ¿Á¶Çϰí Âü¿©ÇÔÀ¸·Î½á ´õ¿í´õ Ȱ¹ßÇÑ ÇмúȰµ¿ÀÌ ÀÌ·ç¾î Áú °ÍÀ¸·Î ±â´ëµÈ´Ù.